{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:11:07Z","timestamp":1787839867501,"version":"build-2784847793"},"reference-count":42,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>Individuals with underlying metabolic disorders are a potential high-risk group for vaccine-preventable diseases. Newborn metabolic screening has provided a means of early identification and treatment for many of these disorders, whereas childhood immunization is one of the most effective means of decreasing the morbidity and mortality resulting from communicable diseases worldwide. There are very few contraindications to the routine administration of vaccines to the healthy, immunocompetent individual. In certain high-risk groups, such as immunocompromised patients, gravid females, and those with a history of previous anaphylactic reaction to a vaccine or its components, selective withholding of immunizations must be considered to decrease potential adverse events. A detailed analysis of the medical literature revealed few specific recommendations regarding appropriate immunization techniques for patients with metabolic disorders. In this review we detail the major metabolic disorder subtypes, elaborate on the available literature on immunizations for patients with these disorders, and provide suggested vaccine recommendations.<\/jats:p>","DOI":"10.1542\/peds.2005-1257","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:57:13Z","timestamp":1151715433000},"page":"e460-e470","source":"Crossref","is-referenced-by-count":23,"title":["Immunizations for Patients With Metabolic Disorders"],"prefix":"10.1542","volume":"118","author":[{"given":"Jeffrey D.","family":"Kingsley","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Varman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases"},{"name":"Department of Pediatrics, Creighton University Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases"},{"name":"Department of Pediatrics, Creighton University Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae A.","family":"Kingsley","sequence":"additional","affiliation":[{"name":"Children's Hospital, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Creighton University Medical Center, Omaha, Nebraska"},{"name":"Combined Division of Metabolism, Creighton University Medical Center and University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"2021120822362783100_R1","unstructured":"American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, ed. 2003 Red Book Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:82"},{"key":"2021120822362783100_R2","unstructured":"Atkinson W, ed. Epidemiology and Prevention of Vaccine-Preventable Diseases. 8th ed. Washington, DC: Department of Health and Human Services, Centers for Disease Control and Prevention; 2004"},{"key":"2021120822362783100_R3","unstructured":"American Academy of Pediatrics. Pertussis. In: Pickering LK, ed. 2003 Red Book Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:484\u2013485"},{"key":"2021120822362783100_R4","unstructured":"Beisel WR. Metabolic response of the host to infections. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Saunders Publishing; 2004:62\u201377"},{"key":"2021120822362783100_R5","doi-asserted-by":"crossref","unstructured":"Scrimshaw NS. Rhoades lecture: effect of infection on nutrient requirements. JPEN J Parenter Enteral Nutr.\u20081991;15:589\u2013600","DOI":"10.1177\/0148607191015006589"},{"key":"2021120822362783100_R6","doi-asserted-by":"crossref","unstructured":"Beisel WR, Sawyer WD, Ryll ED, Crozier D. Metabolic effects of intracellular infections in man. Ann Intern Med.\u20081967;67:744\u2013779","DOI":"10.7326\/0003-4819-67-4-744"},{"key":"2021120822362783100_R7","doi-asserted-by":"crossref","unstructured":"Wilson D, Bressani R, Scrimshaw NS. Infection and nutritional status. I. The effect of chicken pox on nitrogen metabolism in children. Am J Clin Nutr.\u20081961;9:154\u2013158","DOI":"10.1093\/ajcn\/9.2.154"},{"key":"2021120822362783100_R8","doi-asserted-by":"crossref","unstructured":"Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR. The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr.\u20081976;29:997\u20131006","DOI":"10.1093\/ajcn\/29.9.997"},{"key":"2021120822362783100_R9","doi-asserted-by":"crossref","unstructured":"Dierdorf SF, McNiece WL. Anaesthesia and pyruvate dehydrogenase deficiency. Can Anaesth Soc J.\u20081983;30:413\u2013416","DOI":"10.1007\/BF03007865"},{"key":"2021120822362783100_R10","doi-asserted-by":"crossref","unstructured":"Walter JH. Inborn errors of metabolism and pregnancy. J Inherit Metab Dis.\u20082000;23:229\u2013236","DOI":"10.1023\/A:1005679928521"},{"key":"2021120822362783100_R11","doi-asserted-by":"crossref","unstructured":"Leonard JV. The nutritional management of urea cycle disorders. J Pediatr.\u20082001;138(1 suppl):S40\u2013S44; discussion S44\u2013S45","DOI":"10.1067\/mpd.2001.111835"},{"key":"2021120822362783100_R12","doi-asserted-by":"crossref","unstructured":"Steiner LA, Studer W, Baumgartner ER, Frei FJ. Perioperative management of a child with very-long-chain acyl-coenzyme A dehydrogenase deficiency. Paediatr Anaesth.\u20082002;12:187\u2013191","DOI":"10.1046\/j.1460-9592.2002.00809.x"},{"key":"2021120822362783100_R13","unstructured":"Wilcken B. An introduction to nutritional treatment in inborn errors of metabolism: different disorders, different approaches. Southeast Asian J Trop Med Public Health.\u20082003;34(suppl 3):198\u2013201"},{"key":"2021120822362783100_R14","doi-asserted-by":"crossref","unstructured":"Wiese M, Mehlinger SL, Drinkard B, et al. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab.\u20082004;89:591\u2013597","DOI":"10.1210\/jc.2003-030634"},{"key":"2021120822362783100_R15","doi-asserted-by":"crossref","unstructured":"Lindholm H, Lofberg M, Somer H, Naveri H, Sovijarvi A. Abnormal blood lactate accumulation after exercise in patients with multiple mitochondrial DNA deletions and minor muscular symptoms. Clin Physiol Funct Imaging.\u20082004;24:109\u2013115","DOI":"10.1111\/j.1475-097X.2004.00531.x"},{"key":"2021120822362783100_R16","unstructured":"Phenylketonuria (PKU): screening and management. NIH Consens Statement.\u20082000;17(3):1\u201327"},{"key":"2021120822362783100_R17","doi-asserted-by":"crossref","unstructured":"Wyss PA, Carter BE, Boynton SB, Connor E, Fowler B, Roth KS. Renal heme metabolism in hereditary tyrosinemia: use of succinylacetone in rat renal tubules. Biochim Biophys Acta.\u20081991;1070:300\u2013304","DOI":"10.1016\/0005-2736(91)90070-O"},{"key":"2021120822362783100_R18","doi-asserted-by":"crossref","unstructured":"Wyss PA, Boynton SB, Chu J, Roth KS. The physiologic basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat. Clin Sci (Lond).\u20081992;83:81\u201387","DOI":"10.1042\/cs0830081"},{"key":"2021120822362783100_R19","doi-asserted-by":"crossref","unstructured":"Wyss PA, Boynton SB, Chu J, Roth KS. Tissue distribution of succinylacetone in the rat in vivo: a possible basis for neurotoxicity in hereditary infantile tyrosinemia. Biochim Biophys Acta.\u20081993;1182:323\u2013328","DOI":"10.1016\/0925-4439(93)90076-D"},{"key":"2021120822362783100_R20","doi-asserted-by":"crossref","unstructured":"Nagata M, Suzuki M, Kawamura G, et al. Immunological abnormalities in a patient with lysinuric protein intolerance. Eur J Pediatr.\u20081987;146:427\u2013428","DOI":"10.1007\/BF00444955"},{"key":"2021120822362783100_R21","doi-asserted-by":"crossref","unstructured":"Lukkarinen M, Parto K, Ruuskanen O, Vainio O, Kayhty H, Olander RM. B and T cell immunity in patients with lysinuric protein intolerance. Clin Exp Immunol.\u20081999;116:430\u2013434","DOI":"10.1046\/j.1365-2249.1999.00868.x"},{"key":"2021120822362783100_R22","doi-asserted-by":"crossref","unstructured":"Aikoh H, Sasaki M, Sugai K, Yoshida Y, Sakuragawa N. Effective immunoglobulin therapy for brief tonic seizures in methylmalonic acidemia. Brain Dev.\u20081997;19:502\u2013505","DOI":"10.1016\/S0387-7604(97)00059-4"},{"key":"2021120822362783100_R23","unstructured":"Guerra-Moreno J, Barrios N, Santiago-Borrero PJ. Severe neutropenia in an infant with methylmalonic acidemia. Bol Asoc Med P R.\u20082003;95(1):17\u201320"},{"key":"2021120822362783100_R24","doi-asserted-by":"crossref","unstructured":"Martinez-Lage JF, Casas C, Fernandez MA, Puche A, Rodriguez Costa T, Poza M. Macrocephaly, dystonia, and bilateral temporal arachnoid cysts: glutaric aciduria type 1. Childs Nerv Syst.\u20081994;10:198\u2013203","DOI":"10.1007\/BF00301092"},{"key":"2021120822362783100_R25","doi-asserted-by":"crossref","unstructured":"Nagasawa H, Yamaguchi S, Suzuki Y, et al. Neuroradiological findings in glutaric aciduria type I: report of four Japanese patients. Acta Paediatr Jpn.\u20081992;34:409\u2013415","DOI":"10.1111\/j.1442-200X.1992.tb00980.x"},{"key":"2021120822362783100_R26","doi-asserted-by":"crossref","unstructured":"Alkan A, Baysal T, Yakinci C, Sigirci A, Kutlu R. Glutaric aciduria type I diagnosed after poliovirus immunization: magnetic resonance findings. Pediatr Neurol.\u20082002;26:405\u2013407","DOI":"10.1016\/S0887-8994(01)00411-8"},{"key":"2021120822362783100_R27","doi-asserted-by":"crossref","unstructured":"Roth KS, Yang W, Foremann JW, Rothman R, Segal S. Holocarboxylase synthetase deficiency: a biotin-responsive acidemia. J Pediatr.\u20081980;96:845\u2013849","DOI":"10.1016\/S0022-3476(80)80554-3"},{"key":"2021120822362783100_R28","doi-asserted-by":"crossref","unstructured":"Andresen BS, Dobrowolski SF, O'Reilly L, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS\/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet.\u20082001;68:1408\u20131418","DOI":"10.1086\/320602"},{"key":"2021120822362783100_R29","doi-asserted-by":"crossref","unstructured":"Amendt BA, Greene C, Sweetman L, et al. Short-chain acyl-coenzyme A dehydrogenase deficiency: clinical and biochemical studies in two patients. J Clin Invest.\u20081987;79:1303\u20131309","DOI":"10.1172\/JCI112953"},{"key":"2021120822362783100_R30","doi-asserted-by":"crossref","unstructured":"Hale DE, Batshaw ML, Coates PM, et al. Long-chain coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res.\u20081985;19:666\u2013671","DOI":"10.1203\/00006450-198507000-00006"},{"key":"2021120822362783100_R31","doi-asserted-by":"crossref","unstructured":"Wanders RJA, Duran M, Ijilst L, et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase [letter]. Lancet.\u20081989;2:52\u201353","DOI":"10.1016\/S0140-6736(89)90300-0"},{"key":"2021120822362783100_R32","doi-asserted-by":"crossref","unstructured":"Kelley RI. The cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects. Am J Med Genet.\u20081983;16:503\u2013517","DOI":"10.1002\/ajmg.1320160409"},{"key":"2021120822362783100_R33","doi-asserted-by":"crossref","unstructured":"Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain.\u20081997;120:1485\u20131508","DOI":"10.1093\/brain\/120.8.1485"},{"key":"2021120822362783100_R34","doi-asserted-by":"crossref","unstructured":"Okada S, O'Brien JS. Generalized gangliosidosis: beta-galactosidase deficiency. Science.\u20081968;160:1002\u20131004","DOI":"10.1126\/science.160.3831.1002"},{"key":"2021120822362783100_R35","doi-asserted-by":"crossref","unstructured":"Brady RO. The sphingolipidoses. N Engl J Med.\u20081966;275:312\u2013318","DOI":"10.1056\/NEJM196608112750606"},{"key":"2021120822362783100_R36","doi-asserted-by":"crossref","unstructured":"Kappler J, Leinekugel P, Conzelmann E, et al. Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet.\u20081991;86:463\u2013470","DOI":"10.1007\/BF00194634"},{"key":"2021120822362783100_R37","doi-asserted-by":"crossref","unstructured":"Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab.\u20082000;70:1\u20139","DOI":"10.1006\/mgme.2000.2990"},{"key":"2021120822362783100_R38","doi-asserted-by":"crossref","unstructured":"Suzuki M, West C, Beutler E. Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet.\u20082001;109:210\u2013215.","DOI":"10.1007\/s004390100552"},{"key":"2021120822362783100_R39","doi-asserted-by":"crossref","unstructured":"Chou JY, Mansfield BC. Molecular genetics of type I glycogen storage diseases. Trends Endocrinol Metab.\u20081999;10:104\u2013113","DOI":"10.1016\/S1043-2760(98)00123-4"},{"key":"2021120822362783100_R40","doi-asserted-by":"crossref","unstructured":"Rapola J. Lysosomal storage diseases in adults. Pathol Res Pract.\u20081994;190(8):759\u2013766","DOI":"10.1016\/S0344-0338(11)80422-X"},{"key":"2021120822362783100_R41","doi-asserted-by":"crossref","unstructured":"Rees DC, Duley JA, Marinaki AM. Pyrimidine 5\u2032 nucleotidase deficiency. Br J Haematol.\u20082003;120:375\u2013383","DOI":"10.1046\/j.1365-2141.2003.03980.x"},{"key":"2021120822362783100_R42","unstructured":"Girot R, Durandy A, Perignon JL, Griscelli C. Hereditary orotic aciduria: a defect of pyrimidine metabolism with cellular immunodeficiency. Birth Defects Orig Artic Ser.\u20081983;19:313\u2013316"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e460\/1074032\/zpe0080600e460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e460\/1074032\/zpe0080600e460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:17:48Z","timestamp":1639016268000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/2\/e460\/68906\/Immunizations-for-Patients-With-Metabolic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,8,1]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1257","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}